Dynavax Announces Fourth Quarter and Full Year 2018 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/11/2026
- Wall St set to gain on tech rebound, Middle East in focus
- SpaceX prices historic IPO at $135/share in largest ever new listing
- Oil drops as Trump cancels planned strikes against Iran
- Intel rallies as BofA double-upgrades stock on increased CPU, foundry visibility
- Oppenheimer sees little strategic case for Tesla-SpaceX merger
- Needham Starts Hyliion Holdings (HYLN) at Buy
- Adobe CFO Dan Durn to depart company in June 2026
- Oppenheimer Starts SpaceX (SPCX) at Outperform, PT $190, 'space infrastructure appears structurally advantaged'
- Pentagon reportedly locked down, hazmat teams responding
- Alibaba falls on China AI capex report; Citi says selloff is premature
Dynavax Technologies (DVAX) PT Lowered to $23 at RBC Capital
February 27, 2019 6:50 AM ESTRBC Capital analyst Brian Abrahams lowered the price target on Dynavax Technologies (NASDAQ: DVAX) to $23.00 (from $25.00) while maintaining a Outperform rating.
... MoreDynavax (DVAX) Misses Q4 EPS by 3c
February 26, 2019 4:36 PM ESTDynavax (NASDAQ: DVAX) reported Q4 EPS of ($0.64), $0.03 worse than the analyst estimate of ($0.61). Revenue for the quarter came in at $5.3 million versus the consensus estimate of $3.43 million.
Cash, cash equivalents and marketable securities totaled $145.5 million at December 31, 2018, compared to $191.9 million at December 31, 2017. Dynavax plans to borrow $75.0 million under its non-dilutive term loan agreement in the... More
